GSK.SW
Price:
$19.976
Market Cap:
$73.39B
GlaxoSmithKline plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare pr...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2007-12-21
Stock Exchange
SIX
Ticker
GSK.SW
According to GlaxoSmithKline plc’s latest financial reports and current stock price. The company's current PE Ratio is 18.76. This represents a change of 24.93% compared to the average of 15.01 of the last 4 quarters.
The mean historical PE Ratio of GlaxoSmithKline plc over the last ten years is 19.77. The current 18.76 PE Ratio has changed 9.39% with respect to the historical average. Over the past ten years (40 quarters), GSK.SW's PE Ratio was at its highest in in the December 2016 quarter at 59.76. The PE Ratio was at its lowest in in the September 2024 quarter at -266.69.
Average
19.77
Median
13.62
Minimum
3.87
Maximum
67.26
Discovering the peaks and valleys of GlaxoSmithKline plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 956.89%
Maximum Annual PE Ratio = 67.26
Minimum Annual Increase = -67.35%
Minimum Annual PE Ratio = 3.87
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | 21.32 | 78.79% |
| 2023 | 11.92 | 208.13% |
| 2022 | 3.87 | -67.35% |
| 2021 | 11.85 | 26.27% |
| 2020 | 9.39 | -38.69% |
| 2019 | 15.31 | -6.32% |
| 2018 | 16.34 | -52.05% |
| 2017 | 34.08 | -49.33% |
| 2016 | 67.26 | 956.89% |
| 2015 | 6.36 | -67.19% |
The current PE Ratio of GlaxoSmithKline plc (GSK.SW) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
12.37
5-year avg
11.67
10-year avg
19.77
GlaxoSmithKline plc’s PE Ratio is less than EssilorLuxottica S.A. (53.98), less than Becton, Dickinson and Company (34.32), greater than Fresenius Medical Care AG & Co. KGaA (16.31), less than Fresenius SE & Co. KGaA (24.16), greater than Baxter International Inc. (-28.87), greater than DocMorris AG (-1.44), greater than MorphoSys AG (-11.68), greater than ObsEva S.A. (-0.31), greater than IGEA Pharma N.V. (-0.05), less than Spexis AG (0),
| Company | PE Ratio | Market cap |
|---|---|---|
| 53.98 | $88.06B | |
| 34.32 | $72.55B | |
| 16.31 | $22.09B | |
| 24.16 | $15.71B | |
| -28.87 | $42.62B | |
| -1.44 | $404.49M | |
| -11.68 | $2.39B | |
| -0.31 | $140.61K | |
| -0.05 | $505.55K | |
| 0 | $3.86M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GlaxoSmithKline plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like GlaxoSmithKline plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is GlaxoSmithKline plc's PE Ratio?
How is the PE Ratio calculated for GlaxoSmithKline plc (GSK.SW)?
What is the highest PE Ratio for GlaxoSmithKline plc (GSK.SW)?
What is the 3-year average PE Ratio for GlaxoSmithKline plc (GSK.SW)?
What is the 5-year average PE Ratio for GlaxoSmithKline plc (GSK.SW)?
How does the current PE Ratio for GlaxoSmithKline plc (GSK.SW) compare to its historical average?